Presidential Greeting - American Society for Laser Medicine and ...

62 American Society for Laser Medicine and Surgery Abstracts
#211
USE OF A FRACTIONATED Q-SWITCHED RUBY
LASER FOR TREATMENT OF FACIAL
LENTIGINES
Joseph Diehl, Lisa Chipps, Ronald Moy
David Geffen School of Medicine at UCLA, Los Angeles, CA
Background: Fractionated laser technology is associated with
decreased post-treatment morbidity, but has not been applied to
Q-switched ruby lasers (694 nm). Standard Q-switched ruby
lasers have been used effectively for the treatment of pigmented
lesions, but require post-operative wound care and significant
recovery time.
Objective: To report on the suitability of a new fractionated
handpiece for a Q-switched ruby laser for the treatment of facial
lentigines.
Study: Patients with facial lentigines were treated with or
without topical anesthetic with a fractional Q-switched ruby laser
at a fluence that caused tissue whitening.
Results: Fifteen patients were treated one to two times. All
patients experienced clinical improvement in hyperpigmentation,
with minimal post-treatment erythema and crusting.
Conclusion: The fractionated Q-switched ruby laser is an ideal
treatment for facial lentigines, causing clinical improvement with
minimal post-treatment morbidity.
#212
PATIENT SATISFACTION AT 2 AND 6 MONTHS
AFTER A SINGLE NON-INVASIVE
CRYOLIPOLYSIS TREATMENT FOR
SUBCUTANEOUS FAT LAYER REDUCTION
Jeffrey Dover, Michael Kaminer, Maureen Teahan,
Lauren Barrett
SkinCare Physicians, Chestnut Hill, MA
Background: Cryolipolysis is a noninvasive, FDA-approved
procedure used for fat layer reduction. Cryolipolysis, or coldinduced
apoptotic fat cell death, is used to reduce the thickness of
the subcutaneous fat layer without damage to the overlying skin
or associated structures. Clinical studies have reported an
approximate 20% reduction in the fat layer with a single
treatment. Results appear as early as three weeks, with full
results usually visible within 2–6 months. This study evaluated
patient satisfaction with the CoolSculpting procedure after a
single treatment.
Study: Male and female subjects ¼ 18 years of age who had
received a single cryolipolysis procedure (CoolSculpting, Zeltiq,
Inc., Pleasanton, CA) for fat layer reduction on the flanks (love
handles) or abdomen were surveyed by telephone at 2 and 6
months.
Results: Sixteen of 21 patients treated (72.7%) completed the 2month
survey; 15 of the 16 (93.7%) also completed a follow-up
survey at 6 months. At 6 months, 80% of patients reported they
were happy with the results of their treatment, compared with
50% at 2 months. Only one patient at 2 months, and no patients at
6 months, reported that they were not happy with treatment. Of
those who did not say they were happy with their result, most said
they were ‘‘not sure.’’ At 6 months, patients rated their results at
an average of 6.6 on scale of 1–10, compared with 4.2 at 2 months.
Conclusion: In this survey of patients who had received a single
cryolipolysis procedure, both overall satisfaction and patientrated
results of treatment improved significantly from 2 to 6
months, consistent with the gradual nature of improvement
previously reported for cryolipolysis. Six months after treatment,
overall satisfaction was very high, with 80% of patients reporting
they were happy with their results.
#213
THE USE OF A PERFLUROCARBON EMULSION
AS A POST-LASER TREATMENT
J. Kevin Duplechain, Mark G. Rubin,
Mark G. Fontenot
Tulane University, Lafayette, LA; Lasky Clinic, Beverly Hills, CA;
Gabriel Medical, Palo Alto, CA
Background: Carbon dioxide laser resurfacing continues to be a
very desirable treatment with the advent of fractionated
treatment devices. Complications still develop at undesirable
rates with several recent articles demonstrating the effect of
infection and varied treatment protocols. The use of a
perflurocarbon emulsion was undertaken in 100 consecutive
patients to determine if reduced complications with such an
emulsion were possible.
Study: One hundred patients underwent CO2 resurfacing. Each
patient was treated with the perflurocarbon emulsion three times
daily. Antivirals were prescribed in all cases, but the use of
antibiotics and steroids were excluded. Patients were advised to
report any side effects during the treatment which including
increased erythema, prolonged healing, or signs of infections.
Results: Ninety-nine patients completed the study. One patient
withdrew from the study to use a petrolatum based product
because of perceived dryness. The patient developed an acneform
eruption and was subsequently treated with the perflurocarbon
emulsion with good success. Two patients developed a single site
pustule that was treated by unroofing the lesion with a needle. No
other complications were noted.
Conclusion: The use of a perflurocarbon emulsion provides an
excellent post laser treatment with less complications than
previously reported when petrolatum based products were
utilized. Overall patient satisfaction with the laser treatment and
the post-laser emulsion were very high indicating that minimizing
post-treatment complications may increase patient interest in
laser skin resurfacing.
#214
COMBINATION 15% AZELAIC ACID GEL AND
INTENSE PULSE LIGHT THERAPY FOR MILD TO
MODERATE ROSACEA
Sabrina Fabi, Jennifer Peterson, Mitchel Goldman
Goldman Butterwick & Associates, Cosmetic Laser Surgery,
San Diego, CA
Background: Rosacea is a chronic inflammatory skin condition
of adulthood that affects women more commonly than men,
though men may suffer from more severe rosacea. Clinical
manifestations include telengiectasias, centrofacial erythema,
and acneiform papules and pustules. The inflammatory
papulopustular eruption of rosacea can be treated with both
topical and oral medications, including topical sulfa agents,
metronidazole, azelaic acid, and oral antibiotics. Although overall
redness is often decreased with the use of 15% azelaic acid gel,
telengiectasias are best treated with vascular laser surgery. We
propose that the combination of 15% azelaic acid gel and IPL
therapy will have an improved treatment outcome in the
treatment of rosacea compared to laser therapy alone.